Centre for Primary Care & Health Services Research Seminar: ‘Risk of glucocorticoid therapy in polymyalgia rheumatica & giant cell arteritis patients with co-existing type 2 diabetes’
|Starts:||13:00 17 Nov 2020|
|Ends:||14:00 17 Nov 2020|
|What is it:||Seminar|
|Organiser:||Faculty of Biology, Medicine and Health|
|Who is it for:||University staff, Current University students|
|Speaker:||Dr Milica Blagojevic-Bucknall|
At this seminar, our guest speaker Dr Milica Blagojevic-Bucknall from Keele University will present a talk titled “Risk of glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis patients with co-existing type 2 diabetes”.
Polymyalgia rheumatica (PMR) and giant cell arteritis are both treated with glucocorticoids. Glucocorticoids exacerbate pre-existing diabetes and increases the risk of associated complications, however the impact of this has not been quantified. This study investigates the impact of glucocorticoid treatment on co-existing type 2 diabetes. GCA and PMR form two contrasting groups; one high dose group (GCA) and one medium/low dose group (PMR). The study uses Clinical Practice Research Datalink (CPRD) and we assess sensitivity to unmeasured confounding.
For Zoom details, please email: CPC.email@example.com
Dr Milica Blagojevic-Bucknall
Role: Senior Lecturer in Statistics
Organisation: Keele University
Travel and Contact Information